Buys
Open market- Shares
- +130,000
- Avg price
- $0.4854
- Total value
- +$63,100
Cameron John Reynolds - President and CEO, Director at VOLITIONRX LTD
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- VNRX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Cameron John Reynolds in VOLITIONRX LTD
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +130,000
- Share %
- 100%
- Total value
- +$63,100
Reported holdings for Cameron John Reynolds in VOLITIONRX LTD
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 3,115,547
- Estimated value
- $778,886
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- Direct
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 1,007,718
- Estimated value
- $251,929
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- By Concord International, Inc.
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Common Stock
- Shares / value
- 34,076
- Estimated value
- $8,519
- Report date
- 26 Feb 2026
- Price
- $0.2500
- Ownership
- By Spouse
Form 4 holding
President and CEO, Director
VOLITIONRX LTD
- Security class
- Warrant (Right to Buy)
- Shares / value
- 110,000
- Estimated value
- Report date
- 14 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Cameron John Reynolds in VOLITIONRX LTD
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.